Georgia

 

HB 276/SB 103

GPhA’s priority legislation, the Pharmacy Patient Fair Practices Act, passed the legislature and now awaits the Governor’s signature.   Companion bills were introduced and passed out on the same day.  As these bills made their way through the legislature they enjoyed unanimous votes at the committee level and on the floors.

These bills gives the Commissioner of Insurance the authority to promulgate rules and regulations to enforce the specific provisions of the PBM chapter.   The bills also prohibit several practices in the commercial market that have adversely impacted patients and pharmacies including:

  • Restricting pharmacies from providing patients information regarding less costly prescription drugs and selling patients less costly drugs.
  • Restricting pharmacies from offering direct delivery services to their patients as an ancillary service.
  • Charging patients copays that are higher than what the pharmacy is paid (copay claw backs).
  • Charging pharmacies fees related to the adjudication of a claim (transaction fees).
  • Recouping money from a pharmacy outside of the audit process unless otherwise authorized or required by law.
  • Penalizing or retaliating against a pharmacy for seeking to enforce their rights under the law.
  • Mandatory mail order under group, blanket, and individual accident and sickness policies (there are several large swaths of the mail order market that this bill will not directly impact due to federal law, ERISA, and other considerations).

HB 206

HB 206  prohibits the Department of Community Health from recouping for corrected clerical errors where no overpayment occurred and limits recoupment to the amount overpaid in cases where a clerical error resulted in an overpayment.   This is similar to a bill that passed in 2016 but was vetoed by the Governor due to provisions that went beyond DCH and applied to all state agencies.  The problematic provisions were removed, we worked out some differences with DCH and we believe this bill will be signed.

HB 249/SB 121

Codifies state’s emergency actions with regard to Naloxone by allowing pharmacists to dispense pursuant to state health officer’s standing order.

 

HB 249

Makes several changes with regard to the Prescription Drug Monitoring Program.  The PDMP will be administered by Department of Public Health (No longer GDNA) and dispensers will be required to submit prescription information at least every 24 hours.   Also imposes certain requirements on prescribers.

 

SB 200

This is a patient/pharmacy friendly bill similar to legislation enacted in many other states.  It prohibits plans from denying coverage for the filling of a prescription to synchronize refilling of multiple prescriptions in accordance with patient, practitioner, and pharmacist plan.  It also prohibits plans from prorating dispensing fees doe partial fills.

 

SB 125

Authorizes PAs to prescribe certain hydrocodone compound products subject to certain conditions and restrictions including dosage and days’ supply limits.

 

SB 41

Requires DME suppliers to obtain a license from the Board of Pharmacy.  This bill contains several exemptions including for pharmacists and pharmacies unless they have a separate company, corporation, or division.

 

SB 193

Allows Pharmacists to provide antibiotics to the sexual partner(s) of a patient with chlamydia or gonorrhea without seeing the partners.